US Stock MarketDetailed Quotes

ONCT Oncternal Therapeutics

Watchlist
  • 8.7200
  • -0.2800-3.11%
Trading May 23 14:08 ET
25.81MMarket Cap-707P/E (TTM)

Oncternal Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-27.70%8.78M
-7.19%41.71M
-19.13%9.64M
-8.26%10.39M
-19.08%9.55M
22.51%12.14M
43.30%44.95M
47.46%11.92M
17.52%11.33M
53.38%11.8M
Selling and administrative expenses
-0.78%3.29M
-5.28%12.75M
-0.76%3.26M
-5.24%3.09M
-4.68%3.07M
-9.89%3.32M
16.06%13.46M
25.59%3.29M
16.52%3.27M
-4.61%3.23M
-General and administrative expense
-0.78%3.29M
-5.28%12.75M
-0.76%3.26M
-5.24%3.09M
-4.68%3.07M
-9.89%3.32M
16.06%13.46M
25.59%3.29M
16.52%3.27M
-4.61%3.23M
Research and development costs
-32.91%6.06M
-9.78%29.75M
-24.19%6.67M
-11.45%7.48M
-24.93%6.58M
29.40%9.03M
36.93%32.98M
46.19%8.8M
-5.81%8.44M
68.74%8.76M
Other operating expenses
-180.30%-569K
47.32%-785K
-73.68%-297K
53.14%-179K
44.50%-106K
72.79%-203K
65.47%-1.49M
69.24%-171K
82.05%-382K
78.37%-191K
Operating profit
27.70%-8.78M
7.19%-41.71M
19.13%-9.64M
8.26%-10.39M
19.08%-9.55M
-22.51%-12.14M
-43.30%-44.95M
-47.46%-11.92M
-17.52%-11.33M
-53.38%-11.8M
Net non-operating interest income expense
-40.40%391K
187.64%2.24M
-8.35%472K
164.00%528K
972.22%579K
8,100.00%656K
2,254.55%777K
7,257.14%515K
2,757.14%200K
575.00%54K
Non-operating interest income
-40.40%391K
187.64%2.24M
-8.35%472K
164.00%528K
972.22%579K
8,100.00%656K
2,254.55%777K
7,257.14%515K
2,757.14%200K
575.00%54K
Other net income (expense)
Income before tax
26.98%-8.39M
10.62%-39.48M
19.61%-9.16M
11.35%-9.86M
23.64%-8.97M
-15.98%-11.49M
-40.97%-44.17M
-41.21%-11.4M
-15.52%-11.13M
-52.84%-11.74M
Income tax
Net income
26.98%-8.39M
10.62%-39.48M
19.61%-9.16M
11.35%-9.86M
23.64%-8.97M
-15.98%-11.49M
-40.97%-44.17M
-41.21%-11.4M
-15.52%-11.13M
-52.84%-11.74M
Net income continuous Operations
26.98%-8.39M
10.62%-39.48M
19.61%-9.16M
11.35%-9.86M
23.64%-8.97M
-15.98%-11.49M
-40.97%-44.17M
-41.21%-11.4M
-15.52%-11.13M
-52.84%-11.74M
Minority interest income
Net income attributable to the parent company
26.98%-8.39M
10.62%-39.48M
19.61%-9.16M
11.35%-9.86M
23.64%-8.97M
-15.98%-11.49M
-40.97%-44.17M
-41.21%-11.4M
-15.52%-11.13M
-52.84%-11.74M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
26.98%-8.39M
10.62%-39.48M
19.61%-9.16M
11.35%-9.86M
23.64%-8.97M
-15.98%-11.49M
-40.97%-44.17M
-41.21%-11.4M
-15.52%-11.13M
-52.84%-11.74M
Basic earnings per share
27.99%-2.83
20.06%-13.43
24.25%-3.03
19.05%-3.4
34.78%-3
1.75%-3.93
-31.25%-16.8
-25.00%-4
-10.53%-4.2
-43.75%-4.6
Diluted earnings per share
27.99%-2.83
20.06%-13.43
24.25%-3.03
19.05%-3.4
34.78%-3
1.75%-3.93
-31.25%-16.8
-25.00%-4
-10.53%-4.2
-43.75%-4.6
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -27.70%8.78M-7.19%41.71M-19.13%9.64M-8.26%10.39M-19.08%9.55M22.51%12.14M43.30%44.95M47.46%11.92M17.52%11.33M53.38%11.8M
Selling and administrative expenses -0.78%3.29M-5.28%12.75M-0.76%3.26M-5.24%3.09M-4.68%3.07M-9.89%3.32M16.06%13.46M25.59%3.29M16.52%3.27M-4.61%3.23M
-General and administrative expense -0.78%3.29M-5.28%12.75M-0.76%3.26M-5.24%3.09M-4.68%3.07M-9.89%3.32M16.06%13.46M25.59%3.29M16.52%3.27M-4.61%3.23M
Research and development costs -32.91%6.06M-9.78%29.75M-24.19%6.67M-11.45%7.48M-24.93%6.58M29.40%9.03M36.93%32.98M46.19%8.8M-5.81%8.44M68.74%8.76M
Other operating expenses -180.30%-569K47.32%-785K-73.68%-297K53.14%-179K44.50%-106K72.79%-203K65.47%-1.49M69.24%-171K82.05%-382K78.37%-191K
Operating profit 27.70%-8.78M7.19%-41.71M19.13%-9.64M8.26%-10.39M19.08%-9.55M-22.51%-12.14M-43.30%-44.95M-47.46%-11.92M-17.52%-11.33M-53.38%-11.8M
Net non-operating interest income expense -40.40%391K187.64%2.24M-8.35%472K164.00%528K972.22%579K8,100.00%656K2,254.55%777K7,257.14%515K2,757.14%200K575.00%54K
Non-operating interest income -40.40%391K187.64%2.24M-8.35%472K164.00%528K972.22%579K8,100.00%656K2,254.55%777K7,257.14%515K2,757.14%200K575.00%54K
Other net income (expense)
Income before tax 26.98%-8.39M10.62%-39.48M19.61%-9.16M11.35%-9.86M23.64%-8.97M-15.98%-11.49M-40.97%-44.17M-41.21%-11.4M-15.52%-11.13M-52.84%-11.74M
Income tax
Net income 26.98%-8.39M10.62%-39.48M19.61%-9.16M11.35%-9.86M23.64%-8.97M-15.98%-11.49M-40.97%-44.17M-41.21%-11.4M-15.52%-11.13M-52.84%-11.74M
Net income continuous Operations 26.98%-8.39M10.62%-39.48M19.61%-9.16M11.35%-9.86M23.64%-8.97M-15.98%-11.49M-40.97%-44.17M-41.21%-11.4M-15.52%-11.13M-52.84%-11.74M
Minority interest income
Net income attributable to the parent company 26.98%-8.39M10.62%-39.48M19.61%-9.16M11.35%-9.86M23.64%-8.97M-15.98%-11.49M-40.97%-44.17M-41.21%-11.4M-15.52%-11.13M-52.84%-11.74M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 26.98%-8.39M10.62%-39.48M19.61%-9.16M11.35%-9.86M23.64%-8.97M-15.98%-11.49M-40.97%-44.17M-41.21%-11.4M-15.52%-11.13M-52.84%-11.74M
Basic earnings per share 27.99%-2.8320.06%-13.4324.25%-3.0319.05%-3.434.78%-31.75%-3.93-31.25%-16.8-25.00%-4-10.53%-4.2-43.75%-4.6
Diluted earnings per share 27.99%-2.8320.06%-13.4324.25%-3.0319.05%-3.434.78%-31.75%-3.93-31.25%-16.8-25.00%-4-10.53%-4.2-43.75%-4.6
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------------Unqualified Opinion with Explanatory Notes------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg